Search Results - "Mehta, Lahar R"

Long-term safety and tolerability of eptinezumab in patients with chronic migraine: a 2-year, open-label, phase 3 trial by Kudrow, David, Cady, Roger K, Allan, Brent, Pederson, Susan M, Hirman, Joe, Mehta, Lahar R, Schaeffler, Barbara A

“…Eptinezumab, an anti-calcitonin gene-related peptide monoclonal antibody recently approved in the United States for preventive treatment of migraine in adults,…”
Get full text

Prolonged-release fampridine and walking and balance in MS: randomised controlled MOBILE trial by Hupperts, Raymond, Lycke, Jan, Short, Christine, Gasperini, Claudio, McNeill, Manjit, Medori, Rossella, Tofil-Kaluza, Agata, Hovenden, Maria, Mehta, Lahar R, Elkins, Jacob

“…Background: Mobility impairment is a common disability in MS and negatively impacts patients’ lives. Objective: Evaluate the effect of prolonged-release (PR)…”
Get full text

Fatal Granulomatous Acanthamoeba Encephalitis Mimicking a Stroke, Diagnosed by Correlation of Results of Sequential Magnetic Resonance Imaging, Biopsy, In Vitro Culture, Immunofluorescence Analysis, and Molecular Analysis by McKellar, Mehri S, Mehta, Lahar R, Greenlee, John E, Hale, Devon C, Booton, Gregory C, Kelly, Daryl J, Fuerst, Paul A, Sriram, Rama, Visvesvara, Govinda S

“…Amebic infections involving the central nervous system are rare and difficult to diagnose. Magnetic resonance imaging (MRI) at timed intervals may be helpful,…”
Get full text

Prolonged-release fampridine treatment improved subject-reported impact of multiple sclerosis: Item-level analysis of the MSIS-29 by Gasperini, Claudio, Hupperts, Raymond, Lycke, Jan, Short, Christine, McNeill, Manjit, Zhong, John, Mehta, Lahar R

“…Abstract Prolonged-release (PR) fampridine is approved to treat walking impairment in persons with multiple sclerosis (MS); however, treatment benefits may…”
Get full text

Polyunsaturated fatty acids and their potential therapeutic role in multiple sclerosis by Mehta, Lahar R, Dworkin, Robert H, Schwid, Steven R

“…Over the past few years, there has been increasing interest in the use of complementary and alternative therapies to treat multiple sclerosis. Dietary…”
Get full text

Neuromyelitis optica spectrum disorder in a patient with systemic lupus erythematosus and anti-phospholipid antibody syndrome by Mehta, Lahar R, Samuelsson, Melissa K, Kleiner, Anatole K, Goodman, Andrew D, Anolik, Jennifer H, Looney, R John, Schwid, Steven R

“…Neuromyelitis optica (NMO) is a demyelinating disease of the central nervous system characterized by severe episodes of optic nerve and spinal cord…”
Get full text

A randomized trial of memantine as treatment for spasticity in multiple sclerosis by Mehta, Lahar R, McDermott, Michael P, Goodman, Andrew D, Schwid, Steven R

“…We report the results of a single center randomized, double-blind, placebo-controlled, parallel group trial of memantine in adults with multiple sclerosis and…”
Get full text

DISEASE-MODIFYING THERAPIES by Mehta, Lahar R, Goodman, Andrew D

“…The introduction of disease-modifying therapies has revolutionized the care of patients with multiple sclerosis (MS). Currently six agents have been…”
Get full text

Sporadic fatal insomnia masquerading as a paraneoplastic cerebellar syndrome by Mehta, Lahar R, Huddleston, Brent J, Skalabrin, Elaine J, Burns, James B, Zou, Wen-Quan, Gambetti, Pierluigi, Chin, Steven S

“…Sporadic fatal insomnia is a rare prion disease that has recently been recognized. To report a unique case of sporadic fatal insomnia in a woman with…”
Get more information

Proof of concept studies for tissue-protective agents in multiple sclerosis by Mehta, LR, Schwid, SR, Arnold, DL, Cutter, GR, Aradhye, S, Balcer, LJ, Calabresi, PA, Cohen, JA, Cole, PE, Glanzman, R, Goelz, S, Inglese, M, Kapoor, R, Kappos, L, Kreitman, R, Lublin, FD, Mann, A, Marrie, RA, O'Looney, P, Polman, CH, Ravina, BM, Reingold, SC, Richert, JR, Sandrock, AW, Waubant, E

“…Background There is considerable interest in tissue-protective treatments for multiple sclerosis (MS). Methods and Objectives We convened a group of MS…”
Get full text